Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants

Oligonucleotides

Volumn 17, Issue 1, 2007, Pages 44-53

  Merl, Sabine ^a   Wessely, Rainer ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; STRUCTURAL PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOPATHOGENIC EFFECT; ENTEROVIRUS; FATALITY; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; PANCREATITIS; PICORNAVIRUS; POINT MUTATION; PRIORITY JOURNAL; RNA INTERFERENCE; SURVIVAL; VIRUS ENCEPHALITIS; VIRUS GENOME; VIRUS HEPATITIS; VIRUS MUTANT; VIRUS MYOCARDITIS; VIRUS REPLICATION;

BASE SEQUENCE; ENTEROVIRUS; GENOME, VIRAL; HELA CELLS; HUMANS; POINT MUTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS REPLICATION;

ENTEROVIRUS; MUS;

EID: 34247500321     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2007.0057     Document Type: Article

References (26)

1. AHN, J., JUN, E.S., LEE, H.S., YOON, S.Y., KIM, D., JOO, C.H., KIM, Y.K., and LEE, H. (2005). A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J. Virol. 79, 8620-8624.
2. BADORFF, C., LEE, G.H., LAMPHEAR, B.J., MARTONE, M.E., CAMPBELL, K.P., RHOADS, R.E., and KNOWLTON, K.U. (1999). Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nature Med. 5, 320-326.
3. BAUER, S., GOTTESMAN, G., SIROTA, L., LITMANOVITZ, I., ASHKENAZI, S., and LEVI, I. (2002). Severe coxsackievirus B infection in preterm newborns treated with pleconaril. Eur. J. Pediatr. 161, 491-493.
4. BODEN, D., PUSCH, O., LEE, F., TUCKER, L., and RAMRATNAM, B. (2003). Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77, 11531-11535.
5. FELDMAN, A.M., and MCNAMARA, D. (2000). Myocarditis. N. Engl. J. Med. 343, 1388-1398.
6. FEUER, R., MENA, I., PAGARIGAN, R.R., HARKINS, S., HASSETT, D.E., and WHITTON, J.L. (2003). Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163, 1379-1393.
7. GITLIN, L., STONE, J.K., and ANDINO, R. (2005). Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79, 1027-1035.
8. HARBORTH, J., ELBASHIR, S.M., BECHERT, K., TUSCHL, T., and WEBER, K. (2001). Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114, 4557-4565.
9. JASCHKE, B., MILZ, S., VOGESER, M., MICHAELIS, C., VORPAHL, M., SCHÖMIG, A., KASTRATI, A., and WESSELY, R. (2004). Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. FASEB J. 18, 1285-1287.
10. KNOWLTON, K.U., and BADORFF, C. (1999). The immune system in viral myocarditis: maintaining the balance. Circ. Res. 85, 559-561.
11. KNOWLTON, K.U., JEON, E.S., BERKLEY, N., WESSELY, R., and HUBER, S. (1996). A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70, 7811-7818.
12. MERL, S., MICHAELIS, C., JASCHKE, B., VORPAHL, M., SEIDL, S., and WESSELY, R. (2005). Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111, 1583-1592.
13. PALLISER, D., CHOWDHURY, D., WANG, Q.Y., LEE, S.J., BRONSON, R.T., KNIPE, D.M., and LIEBERMAN, J. (2006). An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439, 89-94.
14. REYNOLDS, A., LEAKE, D., BOESE, Q., SCARINGE, S., MARSHALL, W.S., and KHVOROVA, A. (2004). Rational siRNA design for RNA interference. Nature Biotechnol. 22, 326-330.
15. ROOS, R.P., STEIN, S., ROUTBORT, M., SENKOWSKI, A., BODWELL, T., and WOLLMANN, R. (1989). Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J. Virol. 63, 4469-4473.
16. ROSSI, J.J. (2006). RNAi as a treatment for HIV-1 infection. Biotechniques Suppl, 25-29.
17. STEVENSON, M. (2004). Therapeutic potential of RNA interference. N. Engl. J. Med. 351, 1772-1777.
18. VAN HOUTEN, N., BOUCHARD, P.E., MORASKA, A., and HUBER, S.A. (1991). Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65, 1286-1290.
19. WESSELY, R., HENKE, A., ZELL, R., KANDOLF, R., and KNOWLTON, K.U. (1998a). Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98, 450-457.
20. WESSELY, R., KLINGEL, K., SANTANA, L.F., DALTON, N., HONGO, M., LEDERER, W., KANDOLF, R., and KNOWLTON, K.U. (1998b). Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102, 1444-1453.
21. WESSELY, R., KLINGEL, K., KNOWLTON, K.U., and KANDOLF, R. (2001). Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103, 756-761.
22. WOODRUFF, J.F. (1980). Viral myocarditis. A review. Am. J. Pathol. 101, 425-484.
23. YOKOTA, T., SAKAMOTO, N., ENOMOTO, N., TANABE, Y., MIYAGISHI, M., MAEKAWA, S., YI, L., KUROSAKI, M., TAIRA, K., WATANABE, M., and MIZUSAWA, H. (2003). Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4, 602-608.
24. YOSHINARI, K., MIYAGISHI, M., and TAIRA, K. (2004). Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res. 32, 691-699.
25. YUAN, J., CHEUNG, P., ZHANG, H., CHAU, D., and YANG, D. (2005). Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J. Virol. 79, 2151-2159.
26. ZARAGOZA, C., OCAMPO, C.J., SAURA, M., BAO, C., LEPPO, M., LAFOND-WALKER, A., THIEMANN, D.R., HRUBAN, R., and LOWENSTEIN, C.J. (1999). Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J. Immunol. 163, 5497-5504.